Sagimet Biosciences Inc. - 10-Q Filing

Sagimet Biosciences reports quarterly financial results including research and development expense updates for the period ending September 30, 2025.

SEC EDGAR ·

Tickers: $SGMT

Read the full article at SEC EDGAR

More Regulatory news